Armata Pharmaceuticals, Inc.

Armata is a clinical‐stage biotechnology company focused on the development of pathogen‐specific bacteriophage therapeutics for the treatment of antibiotic‐resistant and difficult‐to‐treat bacterial infections using its proprietary bacteriophage‐based technology. Armata is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates…More for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. Armata is committed to advancing phage with drug development expertise that spans bench to clinic including in‐house phage‐specific GMP manufacturing.